From: Molecular profiling of basal cell carcinomas in young patients
Different studies
PTCH1
TP53
SMO
RB1
MYCN
Reifenberger et al. [14]
50–85%
Jayaraman et al. [15]
75%
66%
–
Bonilla et al. [13]
73%
61%
20%
< 1%
30%
Maturo et al. [16]
59%
31%
Our study
64%
21%
11%
7%
4%
